Gary L. Kunz

Array ( [id] => 3688233 [patent_doc_number] => 05603978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Esterified propylene oxide-extended glycerols useful as fat substitutes' [patent_app_type] => 1 [patent_app_number] => 8/476815 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7156 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/603/05603978.pdf [firstpage_image] =>[orig_patent_app_number] => 476815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652632 [patent_doc_number] => 05658548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Nucleic acid purification on silica gel and glass mixtures' [patent_app_type] => 1 [patent_app_number] => 8/476849 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11691 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658548.pdf [firstpage_image] =>[orig_patent_app_number] => 476849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698069 [patent_doc_number] => 05596094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Process for preparing 2\' -0- alkyl adenosine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/485595 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4824 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596094.pdf [firstpage_image] =>[orig_patent_app_number] => 485595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732098 [patent_doc_number] => 05665709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Polysubstituted benzimidazole nucleosides as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/472982 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 48553 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 422 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665709.pdf [firstpage_image] =>[orig_patent_app_number] => 472982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664561 [patent_doc_number] => 05668113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral infections' [patent_app_type] => 1 [patent_app_number] => 8/482823 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7451 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668113.pdf [firstpage_image] =>[orig_patent_app_number] => 482823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1506992 [patent_doc_number] => 06440693 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'TNF receptors, TNF binding proteins and DNAS coding for them' [patent_app_type] => B1 [patent_app_number] => 08/484307 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 23034 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440693.pdf [firstpage_image] =>[orig_patent_app_number] => 08484307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619128 [patent_doc_number] => 05614391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'm-RNA purification' [patent_app_type] => 1 [patent_app_number] => 8/487108 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3005 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614391.pdf [firstpage_image] =>[orig_patent_app_number] => 487108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048525 [patent_doc_number] => 05968914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/472210 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24298 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968914.pdf [firstpage_image] =>[orig_patent_app_number] => 472210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617915 [patent_doc_number] => 05641534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Fat-type organoleptic ingredients comprising esterified propylene oxide-extended glycerols' [patent_app_type] => 1 [patent_app_number] => 8/476816 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7154 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641534.pdf [firstpage_image] =>[orig_patent_app_number] => 476816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701108 [patent_doc_number] => 05646125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Polysubstituted benzimidazoles as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/473037 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 48254 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646125.pdf [firstpage_image] =>[orig_patent_app_number] => 473037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3667018 [patent_doc_number] => 05668270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Process for the preparation of fludarabine or fludarabine phosphate from guanosine' [patent_app_type] => 1 [patent_app_number] => 8/466524 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23249 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668270.pdf [firstpage_image] =>[orig_patent_app_number] => 466524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706223 [patent_doc_number] => 05654283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Polysubstituted benzimidazoles as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/467946 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 48345 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654283.pdf [firstpage_image] =>[orig_patent_app_number] => 467946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698055 [patent_doc_number] => 05596093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Process for preparing halogenated 2,3-O-cyclocytidine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/469506 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6017 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596093.pdf [firstpage_image] =>[orig_patent_app_number] => 469506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156048 [patent_doc_number] => 06103701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Method for enhancing hematopoiesis with acyl deoxyribonucleosides' [patent_app_type] => 1 [patent_app_number] => 8/470027 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12435 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103701.pdf [firstpage_image] =>[orig_patent_app_number] => 470027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663540 [patent_doc_number] => 05656742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Ring-opened purine compounds for labeling polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/469925 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10410 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656742.pdf [firstpage_image] =>[orig_patent_app_number] => 469925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856750 [patent_doc_number] => 05705490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Polysubstituted benzimidazoles as antiviral agents' [patent_app_type] => 1 [patent_app_number] => 8/471059 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 48271 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705490.pdf [firstpage_image] =>[orig_patent_app_number] => 471059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140815 [patent_doc_number] => 06060459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Enhancing blood cell count with oxypurine nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/465016 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 36501 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 572 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060459.pdf [firstpage_image] =>[orig_patent_app_number] => 465016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936907 [patent_doc_number] => 05871960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof' [patent_app_type] => 1 [patent_app_number] => 8/463081 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32239 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871960.pdf [firstpage_image] =>[orig_patent_app_number] => 463081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596103 [patent_doc_number] => 06384194 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Expression and purification of human interleukin-3 and muteins thereof' [patent_app_type] => B1 [patent_app_number] => 08/461287 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 40 [patent_no_of_words] => 20151 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384194.pdf [firstpage_image] =>[orig_patent_app_number] => 08461287 [rel_patent_id] =>[rel_patent_doc_number] =>)